AZN

Positive news on Oxford/AstraZeneca COVID-19 vaccine could come on Thursday - ITV

Credit: REUTERS/AMANDA PEROBELLI

Positive news on initial trials of the University of Oxford's potential COVID-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source.

LONDON, July 15 (Reuters) - Positive news on initial trials of the University of Oxford's potential COVID-19 vaccine that has been licensed to AstraZeneca AZN.L could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source.

The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results.

The developers of the vaccine earlier this month said they are encouraged by the immune response they have seen in trials so far.

"I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca," Peston said in a blog post on Wednesday.

(Reporting by William Schomberg, writing by Alistair Smout; editing by Michael Holden)

((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More